Oct 2, 2020 8:00 PM ET
iCrowd Newswire – Oct 2, 2020
Zion Research has published a new report titled “Respiratory Disease Testing Market (Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume, and other Tests) for Hospitals, Physician Offices and Clinical Laboratories: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”. According to the report, the global respiratory disease testing market accounted for approximately USD 2.5 Billion in 2015 and is expected to reach approximately USD 3.1 Billion by 2021, growing at a CAGR of around 3.6% between 2016 and 2021.
The respiratory system is one of the vital systems of human body. Respiratory system plays an important role in breathing. Breathing is usually habitual, controlled automatically by the respiratory center at the base of the brain. In addition, the respiratory system also helps to stabilize blood-alkaline balance (pH), remove toxic waste and regulates temperature. Respiratory diseases inhibit this usual operation of the respiratory system and are usually caused as a result of the inhalation of dangerous agents, smoking, and unhealthy lifestyles.
Get Free Sample Of Report – https://www.zionmarketresearch.com/sample/respiratory-disease-testing-market
Respiratory tests such as spirometry, lung volume, peak flow test, imaging, blood gas test, and few other tests are used to diagnose the respiratory disease. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases Moreover, technological advancements and growing aged population would drive the global respiratory disease testing market. However, portable spirometers and low adoption rate of digital radiography may curb the growth of respiratory disease testing market during the forecast period. However, the budding market in Asia-Pacific can act as a potential opportunity for respiratory disease testing market during the forecast period.
Based on the type of the test, the global respiratory disease testing market has been segmented into imaging test, peak flow test, blood gas test, spirometry, lung volume test, and other tests. The imaging test segment holds the largest share of the global respiratory disease testing market. The global respiratory disease testing market is segmented into three major end-user segments i.e. physician offices, hospitals, and clinical laboratories. Hospitals hold the largest market share of respiratory disease testing market in 2015.
North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global respiratory disease testing market. North America holds the largest market share for respiratory disease testing in 2015. The dominance of the region was primarily due to rising popularity of portable devices, increasing the prevalence of respiratory diseases and growing demand for home health care devices and services. The respiratory disease testing market in Asia-Pacific is expected to grow at the fastest growth rate during the forecast period. Latin America is projected to expand at a noticeable growth rate during the forecast period.
Major market players in this industry are ndd Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. and GE Healthcare among others.
This report segments the global respiratory disease testing market as follows:
Global Respiratory Disease Testing Market: Product Segment Analysis
- Lung Volume
- Peak Flow
- Blood Gas
- Other Tests
Global Respiratory Disease Testing Market: End-user Segment Analysis
- Physician Offices
- Clinical Laboratories
Global Respiratory Disease Testing Market: Regional Segment Analysis
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
To view TOC of this report – https://www.zionmarketresearch.com/toc/respiratory-disease-testing-market
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: [email protected]
Keywords: Gobal Respiratory Disease Testing Market